# Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.

> **NCT07325851** · — · NOT_YET_RECRUITING · sponsor: **Bernardino Clavo, MD, PhD** · enrollment: 120 (estimated)

## Conditions studied

- Chemotherapy-Induced Peripheral Neuropathy
- Radiation Toxicity
- Chronic Pain
- Delayed Wound Healing
- Refractory Symptoms

## Interventions

- **PROCEDURE:** Ozone Therapy

## Key facts

- **NCT ID:** NCT07325851
- **Lead sponsor:** Bernardino Clavo, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-14
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07325851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07325851, "Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07325851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*